| 发明名称 |
Stable liquid VEGF antagonist formulations |
| 摘要 |
Formulations of a vascular endothelial growth factor (VEGF)-specific fusion protein antagonist are provided including a pre-lyophilized formulation, a reconstituted lyophilized formulation, and a stable liquid formulation. Preferably, the fusion protein has the sequence of SEQ ID NO:4. |
| 申请公布号 |
US8710004(B2) |
申请公布日期 |
2014.04.29 |
| 申请号 |
US201213428510 |
申请日期 |
2012.03.23 |
| 申请人 |
DIX DANIEL;FRYE KELLY;KAUTZ SUSAN;REGENERON PHARMACEUTICALS, INC. |
发明人 |
DIX DANIEL;FRYE KELLY;KAUTZ SUSAN |
| 分类号 |
A61K38/18;A61K39/00;C07H21/04;C12P21/02 |
主分类号 |
A61K38/18 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
